Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch APOA2 in WB und IHC (p). Er zeigt eine Reaktivität gegenüber Human und wurde in 2+ Publikationen erwähnt.
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogen
This APOA2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 28-56 amino acids from the Central region of human APOA2.
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Haltbarkeit
6 months
Duesing, Charpentier, Marre, Tichet, Hercberg, Balkau, Froguel, Gibson: "Evaluating the association of common APOA2 variants with type 2 diabetes." in: BMC medical genetics, Vol. 10, pp. 13, (2009) (PubMed).
Atta, Crook, Shafique, Johnston, Godsland: "Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II." in: Thrombosis and haemostasis, Vol. 100, Issue 3, pp. 391-6, (2008) (PubMed).
Target
APOA2
(Apolipoprotein A-II (APOA2))
Andere Bezeichnung
APOA2
Hintergrund
APOA2, apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia.